Dose-Independent Pharmacokinetics of a New Reversible Proton Pump Inhibitor, KR-60436, after Intravenous and Oral Administration to Rats: Gastrointestinal First-Pass Effect

  • Yu, Su-Yeon (College of Pharmacy, Seoul National University) ;
  • Shin, Jee-Hyun (College of Pharmacy, Seoul National University) ;
  • Bae, Soo-Kyung (College of Pharmacy, Seoul National University) ;
  • Kim, Eun-Jung (College of Pharmacy, Seoul National University) ;
  • Kim, Yoon-Gyoon (College of Pharmacy, Seoul National University) ;
  • Kim, Sun-Ok (College of Pharmacy, Seoul National University) ;
  • Lee, Dong-Ha (College of Pharmacy, Seoul National University) ;
  • Lim, Hong (College of Pharmacy, Seoul National University) ;
  • Lee, Myung-Gull (College of Pharmacy, Seoul National University)
  • Published : 2003.04.01

Abstract

Dose-independent pharmacokinetic parameters of KR-60436, a new proton pump inhibitor, were evaluated after an intravenous, iv (5, 10, and 20 mg/kg) and an oral (20, 50, and 100 mg/kg) administration to rats. The hepatic, gastric, and intestinal first-pass effects were also measured after iv, intraportal (ip), intragastric (ig), and intraduodenal (id) administration at a dose of 20 mg/kg to rats. (omitted)

Keywords